SCHEMBL18233510

SCHEMBL18233510

NCc1ccc(O)c(-c2ncc(C(F)(F)F)cn2)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LOXL2 Q9Y4K0 5/20 0.44
▸ LOX P28300 2/20 0.43
▸ MAOB P27338 2/20 0.37
▸ ALDH1A1 P00352 2/20 0.36
▸ KDM4E B2RXH2 1/20 0.36
▸ BACE1 P56817 3/20 0.35
▸ TAAR1 Q96RJ0 1/20 0.34
▸ ALOX5AP P20292 1/20 0.34
▸ FEN1 P39748 1/20 0.34
▸ KMT2A Q03164 2/20 0.33
▸ NPBWR1 P48145 1/20 0.33
▸ NR3C2 P08235 1/20 0.33
▸ LOXL3 P58215 1/20 0.33
▸ CNR1 P21554 1/20 0.33
▸ CNR2 P34972 1/20 0.33
▸ BACE2 Q9Y5Z0 1/20 0.33
▸ MEN1 O00255 1/20 0.33
▸ GAA P10253 1/20 0.33
▸ MAPT P10636 1/20 0.33
▸ SMN1; SMN2 Q16637 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL18223646 0.99 LOXL2 (0.45) LOXL2LOXMAOBALDH1A1KDM4E
SCHEMBL18233509 0.83 KIF11 (0.39) LOXL2LOXMAOBALDH1A1KDM4E
Hydrochloric Acid SCHEMBL18224602 0.82 MAOB (0.40) LOXL2LOXMAOBALDH1A1TAAR1
SCHEMBL15674713 0.76 ALDH1A1 (0.46) ALDH1A1KDM4EALOX5APFEN1KMT2A
SCHEMBL21377318 0.75 ERCC1 (0.55) KMT2AMEN1
SCHEMBL18233511 0.74 LOXL2 (0.45) LOXL2LOXALDH1A1KDM4EBACE1
Hydrochloric Acid SCHEMBL18223597 0.73 LOXL2 (0.47) LOXL2LOXMAOBALDH1A1KDM4E
SCHEMBL18233497 0.73 SYK (0.45) LOXL2LOXMAOBTAAR1SMN1; SMN2
Hydrochloric Acid SCHEMBL18223887 0.72 MAOB (0.47) LOXL2LOXMAOBTAAR1SMN1; SMN2
SCHEMBL18224078 0.70 LOXL2 (0.50) LOXL2LOXMAOBALOX5APFEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10626112-B2 Heterocyclic sulfonamide derivative and medicine comprising same EA PHARMA CO., LTD. (JP) 2020-04-21 — — US disclosed
US-20160332999-A1 HETEROCYCLIC SULFONAMIDE DERIVATIVE AND MEDICINE COMPRISING SAME EA PHARMA CO., LTD. (JP) 2016-11-17 — — US disclosed
US-20160332999-A1 HETEROCYCLIC SULFONAMIDE DERIVATIVE AND MEDICINE COMPRISING SAME EA PHARMA CO., LTD. (JP) 2016-11-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160332999-A1 HETEROCYCLIC SULFONAMIDE DERIVATIVE AND MEDICINE COMPRISING SAME TRPA1, TRPV1, TRPV2 LOXL2 2699/4885LOX 3462/4885MAOB 2570/4885
US-10626112-B2 Heterocyclic sulfonamide derivative and medicine comprising same TRPA1, TRPV1, TRPV2 LOXL2 2699/4885LOX 3462/4885MAOB 2570/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback